Replies to post #124 on Equity Field Notes from temporal sources

[DanWebzster]

EYPT is the former pSivida

EYPT was after pSivida acquired Icon and entered into a financial agreement for debt and equity with EW Healthcare

PDUFA for Yutiq is 11/5/18. Yutiq is a treatment for noninfectious posterior uveitis

I would not hold Yutiq close to the PDUFA date. Ph3 results are questionable. Treatment group experienced increased IOP compared to sham. 12% experienced IOP of greater than 11.9 mm Hg while sham was only ~4%

There will be an earnings cc on 5/8/18.